What does Varmaca do?

Varmaca is a pharmacy in Peer. Private Limited, started on 14 May 2020, 1 establishment.

What is the address of Varmaca?

The registered office of Varmaca is located at Baan naar Bree 70, 3990 Peer.

Is Varmaca still active?

Yes. According to the CBE (30 October 2026) Varmaca is active, legal situation “Normale toestand”, started on 14 May 2020.

Is Varmaca registered on Peppol?

Yes, Varmaca is registered on the Peppol network with ID 0208:0746919695.

What is the enterprise number of Varmaca?

The enterprise number of Varmaca is BE0746919695.

When was Varmaca founded?

Varmaca was founded on 14 May 2020.

Who are the directors of Varmaca?

According to the 2025 annual accounts, the directors of Varmaca are: Maarten Vanthoor.

Is Varmaca a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 14 May 2020; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Varmaca make in 2025?

Varmaca posted a profit after taxes of € 238,452 in financial year 2025.

What is the revenue of Varmaca?

As a small company, Varmaca is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 271,237.

How many employees does Varmaca have?

According to the 2025 annual accounts, Varmaca has 0 full-time equivalents (FTE).

Varmaca (Private Limited) - Peer - BE0746919695

Dossier Varmaca, printed on 30 October 2026 from databakkes.be/en/0746919695/varmaca. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 14 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

Varmaca from Peer, company number BE0746919695, closed financial year 2025 with a result of € 238,452 after tax. For that financial year Varmaca recorded a gross margin of € 271,237 and equity of € 244,786. Compared with financial year 2024, the result moved from € 44,723 to € 238,452. Profitable, and profit is growing. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 23, 2026.

What it is worth Growing

€ 244,786

▲ 57% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 238,452

▲ € 193,728 vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 31,366

▲ 15% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 150,000 paid out

63 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents

Average over the fiscal year, from the social balance sheet.

Debts at end 2025

Bank debt ≈ 14 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 1.5 million

€ 103,133 is repaid this year. At this pace the long-term loan is gone in ≈ 14 years.

Owed to suppliers

€ 1,514

▲ 114% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 7,366

▲ 18% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 43,406 Gross margin 2022: € 43,406 First fiscal year in the series	€ 36,303 Gross margin 2023: € 36,303 ▼ 16% vs 2022 (€ 43,406) Unfavourable step	€ 55,265 Gross margin 2024: € 55,265 ▲ 52% vs 2023 (€ 36,303) Favourable step	€ 271,237 Gross margin 2025: € 271,237 ▲ € 215,973 vs 2024 (€ 55,265) Favourable step	▲ € 215,973
Profit after taxes	€ 28,991 Profit after taxes 2022: € 28,991 First fiscal year in the series	€ 25,094 Profit after taxes 2023: € 25,094 ▼ 13% vs 2022 (€ 28,991) Unfavourable step	€ 44,723 Profit after taxes 2024: € 44,723 ▲ 78% vs 2023 (€ 25,094) Favourable step	€ 238,452 Profit after taxes 2025: € 238,452 ▲ € 193,728 vs 2024 (€ 44,723) Favourable step	▲ € 193,728
Equity	€ 98,517 Equity 2022: € 98,517 First fiscal year in the series	€ 123,611 Equity 2023: € 123,611 ▲ 25% vs 2022 (€ 98,517) Favourable step	€ 156,334 Equity 2024: € 156,334 ▲ 26% vs 2023 (€ 123,611) Favourable step	€ 244,786 Equity 2025: € 244,786 ▲ 57% vs 2024 (€ 156,334) Favourable step	▲ 57%
Total debts	€ 10,143 Total debts 2022: € 10,143 First fiscal year in the series	€ 7,729 Total debts 2023: € 7,729 ▼ 24% vs 2022 (€ 10,143) Favourable step	€ 9,260 Total debts 2024: € 9,260 ▲ 20% vs 2023 (€ 7,729) Unfavourable step	€ 1,780,945 Total debts 2025: € 1,780,945 ▲ € 1.8 million vs 2024 (€ 9,260) Unfavourable step	▲ € 1.8 million
Cash	€ 91,389 Cash 2022: € 91,389 First fiscal year in the series	€ 56,295 Cash 2023: € 56,295 ▼ 38% vs 2022 (€ 91,389) Unfavourable step	€ 27,319 Cash 2024: € 27,319 ▼ 51% vs 2023 (€ 56,295) Unfavourable step	€ 31,366 Cash 2025: € 31,366 ▲ 15% vs 2024 (€ 27,319) Favourable step	▲ 15%
Retained profit	€ 95,517 Retained profit 2022: € 95,517 First fiscal year in the series	€ 120,611 Retained profit 2023: € 120,611 ▲ 26% vs 2022 (€ 95,517) Favourable step	€ 153,334 Retained profit 2024: € 153,334 ▲ 27% vs 2023 (€ 120,611) Favourable step	€ 241,786 Retained profit 2025: € 241,786 ▲ 58% vs 2024 (€ 153,334) Favourable step	▲ 58%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 12,000 Dividend 2024: € 12,000 Unchanged (€ 0) Unchanged	€ 150,000 Dividend 2025: € 150,000 ▲ € 138,000 vs 2024 (€ 12,000) Unchanged	▲ € 138,000
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 0 Bank debt 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Bank debt 2024: € 0 Unchanged (€ 0) Unchanged	€ 1,468,131 Bank debt 2025: € 1,468,131 Unchanged (€ 0) Unfavourable step
Balance sheet total	€ 108,659 Balance sheet total 2022: € 108,659 First fiscal year in the series	€ 131,339 Balance sheet total 2023: € 131,339 ▲ 21% vs 2022 (€ 108,659) Unchanged	€ 165,594 Balance sheet total 2024: € 165,594 ▲ 26% vs 2023 (€ 131,339) Unchanged	€ 2,025,731 Balance sheet total 2025: € 2,025,731 ▲ € 1.9 million vs 2024 (€ 165,594) Unchanged	▲ € 1.9 million

Key figures of Varmaca, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Varmaca?

What happened at Varmaca in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 23, 2026 New annual accounts for financial year 2025: profit of € 238,452 (▲ € 193,728 vs 2024). Source: NBB ↗
May 14, 2020 New establishment in Peer. KBO
2020 Maarten Vanthoor became a director. NBB
May 14, 2020 Start of the company according to the CBE. KBO

In short

From € 28,991 profit in 2022 to € 238,452 profit in 2025.

Paid € 79,441 in corporate taxes since 2022.

Best year ever: 2025, with € 238,452 profit.

Paid out € 162,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Maarten Vanthoor

Varmaca

Apotheek Opgrimbie 100%

Behind Varmaca is Maarten Vanthoor. It owns 100% of Apotheek Opgrimbie itself.

Directors

According to the 2025 annual accounts

Maarten Vanthoor

Director

Also active at: APOTHEEK OPGRIMBIE

since 2020

Establishments

Establishment units

Physical locations of this company

Registered office

Baan naar Bree 70

3990 Peer

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

Farmacla

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0746.919.695

VAT number

BE 0746.919.695

Registered office

Baan naar Bree 70, 3990 Peer

Names & denominations

Varmaca

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

14 May 2020

Peppol

Active · Active since 7 Jul 2025

Activities · NACE

Detailhandel in farmaceutische producten

Vervaardiging van geneesmiddelen

Detailhandel in cosmetica en toiletartikelen

Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen

Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels

View on CBE Public ↗ Annual accounts (NBB) ↗

Varmaca

Warning lights

Financials

What happened to Varmaca?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions